Some dispensaries owners warn that moving the plant to a Schedule III classification could open the cannabis market to larger retail pharmacies who already have the capacity and licensure to dispense Schedule III drugs with a prescription.
Since N.J. legalized recreational weed, the 14-year-old medical cannabis program has shrunk — it's down about 50,000 patients since 2022. The post Patients fear medical program is failing without intervention from state officials, cannabis agency appeared first on New Jersey Monitor.
The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, The Associated Press has learned, a historic shift to generations of American drug policy that could have wide ripple effects across the country.
The Manitoba government's plan to let people grow cannabis in their homes is being accompanied by a temporary pause on approval of some new retail outlets.